Skip to main content

Jim Golden, Myra Williams

Premium

Jim Golden, formerly director of bioinformatics at New Haven, Conn.-based CuraGen, has moved on to serve as business development manager at the company’s technology spin-off, 454 Corp.

454, under wraps since its launch on June 2000, “will come out of stealth mode soon,” said Golden.

Myra Williams, former CIO for Glaxo and former president and CEO of Molecular Applications Group, has joined the scientific advisory board of cheminformatics company Synthematix. The company, based in Research Triangle Park, NC, also appointed Tom Cori, former chairman and CEO of Sigma-Aldrich, to its SAB.

Filed under

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.